A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy

CompletedOBSERVATIONAL
Enrollment

106

Participants

Timeline

Start Date

June 29, 2022

Primary Completion Date

June 27, 2024

Study Completion Date

June 27, 2024

Conditions
Urothelial Cancer
Interventions
DRUG

Avelumab

As provided in real world practice

Trial Locations (10)

BS1 3NU

University Hospitals Bristol, Bristol

G12 0YN

Beatson West of Scotland Cancer Centre, Glasgow

GU2 7XX

Royal Surrey County Hospital, Guildford

NW1 2PG

University College London Hospital, London

SE1 9RT

Guy's and St Thomas' Hospital, London

M20 4BX

The Christie NHS Foundation Trust, Manchester

CH63 4JY

Clatterbridge Hospital, Metropolitan Borough of Wirral

OX3 7LE

Churchill Hospital, Oxford

PR2 9HT

Royal Preston Hospital, Preston

SG1 4AB

Lister Hospital, Stevenage

All Listed Sponsors
lead

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

INDUSTRY